The Convertibles market saw record issuance and strong performance in 2020. Will this trend continue in 2021?

Convertible issuance set a new record in 2020 with $113.7 billion of new issuance. The surge in issuance can be attributed primarily to growth sectors, such as Tech and Healthcare, and a significant number of issuers from recovery companies, primarily in the Consumer Discretionary sector, many of which were negatively impacted by the Covid-19 crisis. Sector and issuer composition has significantly broadened the investible landscape, especially as we enter an economic recovery.

While we expect 2021 issuance to remain strong, the pace will likely moderate as market conditions normalize over the year. We believe issuance supply will be supported by the sharp earnings rebound from a cyclical recovery, healthy equity valuations, increased issuer capital spending, attractive pricing, and the presence of several large issuers. In addition, since there is still uncertainty on the timeline of normalization, we believe issuers will utilize Convertibles as a low-cost source of new capital to address any potential liquidity events and for liquidity insurance purposes.

Company Insights

Recent Updates

The yearly awards, presented by Envestnet | PMC and Investment Advisor recognize active managers who have beaten their benchmarks, shown solid performance in general over time and are the best in their respective asset class.  Eligibility requires the portfolio manager have $200 million in assets and three years of experience.  Additionally, the managers also need to be open to new investment on the Envestnet platform.  Award finalists were chosen using Envestnet | PMC’s proprietary, systematic, and multi-factor methodology for evaluating managers, which takes a variety of qualitative and quantitative criteria into consideration, such as investment process and style, performance, firm profile, customer service, and tax efficiency. SSI Investment Management did not pay to participate.

Past performance is not necessarily indicative of future results.